Heron Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 26, 2026

Group 1 - Heron Therapeutics, Inc. will host a conference call and live webcast on February 26, 2026, at 8:30 a.m. ET to report fourth quarter and full year 2025 financial results and discuss recent business highlights [1] - Participants can access the conference call via a registration link for dial-in details and are encouraged to join fifteen minutes early to avoid delays [2] - An archive of the teleconference and webcast will be available on Heron's website for 60 days following the call [2] Group 2 - Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on developing and commercializing therapeutic innovations to improve medical care for patients [3] - The company utilizes advanced science, patented technologies, and an innovative approach to drug discovery and development to create a portfolio of products aimed at enhancing the standard-of-care for acute care and oncology patients [3]